Clinical reference Biomarker Directory
Back to directory

Squamous cell carcinoma antigen

Established

SCC antigen is a monitoring tumor marker for squamous cell carcinomas across several body sites.

Also known as SCC antigen SCCA
In plain language

This blood test rises in certain skin-type (squamous) cancers, found in places like the cervix, lungs, and head/neck area. It's mainly used to track treatment and watch for cancer coming back, not to screen for or diagnose it, and some benign skin conditions can also raise it a bit.

Biomarker & context

Squamous cell carcinoma antigen (SCC antigen) is a tumor marker elevated in squamous cell carcinomas arising from the cervix, head and neck, lung, and esophagus.

What it indicates

Elevated SCC antigen supports monitoring treatment response and detecting recurrence in squamous cell carcinomas of these sites, but like most tumor markers discussed in this list, it is used mainly for monitoring rather than screening or initial diagnosis due to limited sensitivity and specificity.

Diagnosis & clinical testing

Measured via serum immunoassay; benign skin conditions (psoriasis, eczema) and other non-malignant conditions can also mildly elevate SCC antigen, since the underlying protein is a normal component of squamous epithelium, contributing to background noise in interpretation.

Guiding treatment

Rising SCC antigen during surveillance for cervical, head/neck, or lung squamous cell carcinoma prompts further imaging workup for possible recurrence, always interpreted alongside clinical exam and imaging rather than in isolation.

Clinical significance

Some benign skin conditions can also mildly elevate this marker, since it's a normal squamous epithelium protein.

References
  1. General oncology reference literature on SCC antigen use in cervical, head/neck, and lung squamous cell carcinoma monitoring.